ÖSTERSUND, Sweden--(BUSINESS WIRE)--Regulatory News:
Skanska (STO:SKAB) has signed a contract to build an expansion of the UF Shands Cardiovascular/Neuroscience Hospital in Gainesville, FL, USA. The contract value, USD 225 M, about SEK 1.5 billion, will be included in order bookings for Skanska USA Building for the first quarter of 2014.
The 48,000 square meter conversion will be constructed adjacent to the UF Health / Shands Cancer Hospital, which was completed by Skanska USA in 2009.
Construction will begin in fall/winter 2014, and is expected to be completed in the fall of 2017.
Skanska USA is one of the leading development and construction companies in the country, consisting of four business units: Skanska USA Building, which specializes in building construction; Skanska USA Civil, specialized in civil infrastructure; Skanska Infrastructure Development North America, which develops public-private partnerships; and Skanska USA Commercial Development, which develops commercial projects in select U.S. markets. Headquartered in New York, Skanska USA has more than 9,600 employees and its 2013 revenues were SEK 43.5 billion.
Skanska AB may be required to disclose the information provided herein pursuant to the Securities Markets Act. Skanska is one of the world’s leading project development and construction groups with expertise in construction, development of commercial and residential projects and public-private partnerships. Based on its global green experience, Skanska aims to be the clients' first choice for Green solutions. The Group currently has 57,000 employees in selected home markets in Europe, in the US and Latin America.
Headquartered in Stockholm, Sweden and listed on the Stockholm Stock Exchange, Skanska's sales in 2013 totaled SEK 136 billion.
This and previous releases can also be found at www.skanska.com
This information was brought to you by Cision http://news.cision.com